Oral Solid Dosage Pharmaceutical Formulation Market is projected to achieve US$ 8,95,636.0 million by 2034 at a CAGR of 3.7%.

Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...

Shares of Eli Lilly & Co. LLY advanced 1.11% to $915.04 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 and ...

A good example is the healthcare sector. It has been out of favour for a few years and valuations are attractive. Yet the fundamentals continue to be sound, if not improving, and concerns are ...

GC Therapeutics, Inc. (GCTx), announced its launch today to scale and unlock the next generation of cell therapy. Invented and developed by a world-class team of scientists in the lab of professor ...

Natural supplements have “very mild effects” on weight loss based on what Dr. Ali has seen. There is some data to suggest ...

Hims & Hers Health to offer compounded Wegovy for $99/month to eligible military, teachers, nurses, and first responders.

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

The company launched a website on Tuesday that allows users ... the medicines they need when they need them.” In January, Eli Lilly & Co. launched its LillyDirect portal to sell popular obesity ...

according to the company’s website. Most U.S. patients are covered by health insurance and would likely pay less for the drugs. Novo and rival Eli Lilly, which makes the weight loss drug Zepbound, ...

There is soaring demand for weight-loss drugs in the GLP-1 class, and the company will now sell it to certain professions for ...

They own securities in 3M, Ecolab, Target, Xcel Energy, General Mills, UnitedHealth Group, Amazon, Apple, Chevron, Eli Lilly ...